10x Genomics, Inc. Revenue
10x Genomics, Inc. (TXG) reported Revenue of $151.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-07
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $151.04M, a 12.65% decline year-over-year.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $150.84M, a 2.61% decline year-over-year.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $166.03M, a 0.61% increase year-over-year.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $149.00M, a 1.75% decline year-over-year.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $642.82M, a 5.25% increase from fiscal 2024.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $610.78M, a 1.28% decline from fiscal 2023.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $618.73M, a 19.81% increase from fiscal 2022.
- 10x Genomics, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $516.41M, a 5.28% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $151.04M 10-Q · filed 2026-08-07 | $301.88M 10-Q · filed 2026-08-07 | $467.91M derived: sum of 3 quarters · filed 2026-08-07 | $616.91M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $150.84M 10-Q · filed 2026-05-08 | $316.87M derived: sum of 2 quarters · filed 2026-05-08 | $465.88M derived: sum of 3 quarters · filed 2026-05-08 | $638.78M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $166.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $315.03M derived: sum of 2 quarters · filed 2026-02-13 | $487.94M derived: sum of 3 quarters · filed 2026-08-07 | $642.82M 10-K · filed 2026-02-13 |
| 2025-09-30 | $149.00M 10-Q · filed 2025-11-07 | $321.91M derived: sum of 2 quarters · filed 2026-08-07 | $476.79M 10-Q · filed 2025-11-07 | $641.81M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $172.91M 10-Q · filed 2026-08-07 | $327.79M 10-Q · filed 2026-08-07 | $492.81M derived: sum of 3 quarters · filed 2026-08-07 | $644.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $154.88M 10-Q · filed 2026-05-08 | $319.90M derived: sum of 2 quarters · filed 2026-05-08 | $471.56M derived: sum of 3 quarters · filed 2026-05-08 | $624.66M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $165.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $316.68M derived: sum of 2 quarters · filed 2026-02-13 | $469.78M derived: sum of 3 quarters · filed 2026-02-13 | $610.78M 10-K · filed 2026-02-13 |
| 2024-09-30 | $151.65M 10-Q · filed 2025-11-07 | $304.76M derived: sum of 2 quarters · filed 2025-11-07 | $445.76M 10-Q · filed 2025-11-07 | $629.74M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $153.10M 10-Q · filed 2025-08-08 | $294.11M 10-Q · filed 2025-08-08 | $478.09M derived: sum of 3 quarters · filed 2026-02-13 | $631.73M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $141.01M 10-Q · filed 2025-05-09 | $324.99M derived: sum of 2 quarters · filed 2026-02-13 | $478.63M derived: sum of 3 quarters · filed 2026-02-13 | $625.45M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $183.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $337.62M derived: sum of 2 quarters · filed 2026-02-13 | $484.44M derived: sum of 3 quarters · filed 2026-02-13 | $618.73M 10-K · filed 2026-02-13 |
| 2023-09-30 | $153.64M 10-Q · filed 2024-10-29 | $300.46M derived: sum of 2 quarters · filed 2024-10-29 | $434.75M 10-Q · filed 2024-10-29 | $590.98M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $146.82M 10-Q · filed 2024-08-08 | $281.10M 10-Q · filed 2024-08-08 | $437.34M derived: sum of 3 quarters · filed 2025-02-13 | $568.41M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $134.28M 10-Q · filed 2024-04-30 | $290.52M derived: sum of 2 quarters · filed 2025-02-13 | $421.59M derived: sum of 3 quarters · filed 2025-02-13 | $536.20M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $156.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $287.30M derived: sum of 2 quarters · filed 2025-02-13 | $401.91M derived: sum of 3 quarters · filed 2025-02-13 | $516.41M 10-K · filed 2025-02-13 |
| 2022-09-30 | $131.07M 10-Q · filed 2023-11-03 | $245.68M derived: sum of 2 quarters · filed 2023-11-03 | $360.18M 10-Q · filed 2023-11-03 | $503.71M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $114.61M 10-Q · filed 2023-08-04 | $229.10M 10-Q · filed 2023-08-04 | $372.63M derived: sum of 3 quarters · filed 2024-02-15 | $497.93M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $114.50M 10-Q · filed 2023-05-04 | $258.03M derived: sum of 2 quarters · filed 2024-02-15 | $383.32M derived: sum of 3 quarters · filed 2024-02-15 | $499.17M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $143.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $268.83M derived: sum of 2 quarters · filed 2024-02-15 | $384.67M derived: sum of 3 quarters · filed 2024-02-15 | $490.49M 10-K · filed 2024-02-15 |
| 2021-09-30 | $125.30M 10-Q · filed 2022-11-03 | $241.14M derived: sum of 2 quarters · filed 2022-11-03 | $346.96M 10-Q · filed 2022-11-03 | $459.18M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $115.84M 10-Q · filed 2022-08-09 | $221.66M 10-Q · filed 2022-08-09 | $333.88M derived: sum of 3 quarters · filed 2023-02-16 | $405.70M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $105.82M 10-Q · filed 2022-05-05 | $218.04M derived: sum of 2 quarters · filed 2023-02-16 | $289.86M derived: sum of 3 quarters · filed 2023-02-16 | $332.76M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $112.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $184.03M derived: sum of 2 quarters · filed 2023-02-16 | $226.94M derived: sum of 3 quarters · filed 2023-02-16 | $298.85M 10-K · filed 2023-02-16 |
| 2020-09-30 | $71.82M 10-Q · filed 2021-11-05 | $114.72M derived: sum of 2 quarters · filed 2021-11-05 | $186.63M 10-Q · filed 2021-11-05 | $261.92M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $42.91M 10-Q · filed 2021-08-06 | $114.81M 10-Q · filed 2021-08-06 | $190.10M derived: sum of 3 quarters · filed 2022-02-18 | $251.31M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $71.91M 10-Q · filed 2021-05-07 | $147.19M derived: sum of 2 quarters · filed 2022-02-18 | $208.40M derived: sum of 3 quarters · filed 2022-02-18 | $264.22M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $75.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $136.50M derived: sum of 2 quarters · filed 2022-02-18 | $192.31M derived: sum of 3 quarters · filed 2022-02-18 | $245.89M 10-K · filed 2022-02-18 |
| 2019-09-30 | $61.21M 10-Q · filed 2020-11-12 | $117.03M derived: sum of 2 quarters · filed 2020-11-12 | $170.60M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $55.82M 10-Q · filed 2020-08-12 | $109.40M 10-Q · filed 2020-08-12 | ||
| 2018-12-31 | $146.31M 10-K · filed 2021-02-26 |